1 Motion Sickness |
|
1 | (32) |
|
1.1 Definition of Motion Sickness |
|
|
3 | (3) |
|
1.2 Symptoms and Signs of Motion Sickness |
|
|
6 | (7) |
|
1.3 Physiological Responses |
|
|
13 | (4) |
|
1.4 Symptoms and Signs of Simulator Sickness |
|
|
17 | (3) |
|
1.5 Performance Degradation and Effect of Severity and Motion Sickness |
|
|
20 | (2) |
|
|
22 | (4) |
|
1.7 A Sopite Syndrome Thesis |
|
|
26 | (2) |
|
1.8 Motion Sickness as a Stressor |
|
|
28 | (1) |
|
|
29 | (1) |
|
|
29 | (4) |
2 Incidence of Motion Sickness |
|
33 | (24) |
|
|
35 | (4) |
|
|
39 | (4) |
|
2.3 Space Adaptation Syndrome |
|
|
43 | (3) |
|
|
46 | (3) |
|
2.5 Sickness Related to Virtual Reality Systems |
|
|
49 | (2) |
|
2.6 Motion Sickness in Other Forms of Provocative Motion |
|
|
51 | (1) |
|
|
52 | (1) |
|
|
52 | (5) |
3 Correlates of Susceptibility to Motion Sickness |
|
57 | (12) |
|
3.1 Motion Sickness Related to Age |
|
|
57 | (1) |
|
3.2 Motion Sickness Related to the Sex of the Subject |
|
|
58 | (4) |
|
3.3 Why Are Females More Likely to Be Motion Sick? |
|
|
62 | (1) |
|
3.4 Motion Sickness Related to Race or Culture |
|
|
63 | (1) |
|
3.5 Motion Sickness Related to Physical Fitness |
|
|
63 | (4) |
|
|
67 | (1) |
|
|
67 | (2) |
4 Characteristics of the Provocative Motion Stimuli |
|
69 | (24) |
|
|
70 | (7) |
|
4.2 Motion Simulator Studies |
|
|
77 | (6) |
|
|
83 | (3) |
|
|
86 | (1) |
|
4.5 Parabolic Flight Studies |
|
|
87 | (1) |
|
|
88 | (1) |
|
4.7 Motion Frequencies of Concern |
|
|
89 | (1) |
|
|
90 | (1) |
|
|
91 | (2) |
5 Physiological Mechanisms Underlying Motion Sickness |
|
93 | (20) |
|
5.1 Vestibular Overstimulation Theory |
|
|
94 | (1) |
|
5.2 Sensory Conflict Theory |
|
|
95 | (2) |
|
5.3 Neural Mismatch Hypothesis |
|
|
97 | (1) |
|
5.4 Visual/Inertial Rearrangements |
|
|
98 | (1) |
|
5.5 Canal/Otolith Rearrangements |
|
|
99 | (1) |
|
5.6 Vestibular/Proprioceptor Mismatch |
|
|
99 | (2) |
|
5.7 Heuristic Mathematical Model |
|
|
101 | (1) |
|
5.8 Subjective Vertical Conflict Theory |
|
|
101 | (1) |
|
5.9 Postural Instability Theory |
|
|
102 | (1) |
|
5.10 Other Intermodality Conflicts |
|
|
102 | (2) |
|
5.11 Treisman's Evolutionary Hypothesis |
|
|
104 | (2) |
|
5.12 Nystagmus Hypothesis |
|
|
106 | (2) |
|
|
108 | (1) |
|
|
109 | (4) |
6 Psychological Mechanisms That Exacerbate Motion Sickness |
|
113 | (16) |
|
|
115 | (2) |
|
|
117 | (3) |
|
6.3 Measured Stress Responses |
|
|
120 | (2) |
|
6.4 Relationship of Salivary Gland Function to Personality and Motion Sickness |
|
|
122 | (2) |
|
6.5 Theoretical Considerations |
|
|
124 | (1) |
|
|
125 | (1) |
|
|
126 | (3) |
7 Adaptation to Provocative Motion |
|
129 | (18) |
|
7.1 Protective Adaptation |
|
|
130 | (2) |
|
|
132 | (2) |
|
7.3 Adaptation-Specific or General? |
|
|
134 | (2) |
|
7.4 Reduction of Visually-Induced Motion Sickness Elicited by Changes in Illumination Wavelength |
|
|
136 | (4) |
|
7.5 Generalisation of Tolerance to Motion Environments |
|
|
140 | (3) |
|
7.6 The Transfer of Adaptation Between Actual and Simulated Rotary Stimulation |
|
|
143 | (2) |
|
|
145 | (1) |
|
|
145 | (2) |
8 Prediction of Susceptibility to Motion Sickness |
|
147 | (18) |
|
8.1 Prevention of Motion Sickness by Candidate Selection |
|
|
148 | (1) |
|
8.2 Selection by Means of Motion Sickness Questionnaires |
|
|
148 | (2) |
|
8.3 Tests for Grading Susceptibility to Motion Sickness |
|
|
150 | (11) |
|
8.4 Comments Regarding Prediction |
|
|
161 | (1) |
|
|
162 | (1) |
|
|
163 | (2) |
9 Prevention of Motion Sickness |
|
165 | (18) |
|
|
167 | (1) |
|
|
167 | (3) |
|
9.3 The Mitigation of Specific Precipitating Factors |
|
|
170 | (5) |
|
9.4 Benefit of Seeing the Horizon |
|
|
175 | (1) |
|
9.5 Use of an Artificial Horizon |
|
|
176 | (1) |
|
9.6 Factors Influencing Habituation to Motion |
|
|
177 | (1) |
|
9.7 Prevention of Motion Sickness by Vestibular Training |
|
|
178 | (1) |
|
9.8 Factors Related to Simulator Sickness |
|
|
179 | (2) |
|
|
181 | (1) |
|
|
181 | (2) |
10 Pharmacological Treatment of Motion Sickness |
|
183 | (36) |
|
10.1 Scopolamine (Hyoscine Hydrobromide) |
|
|
185 | (11) |
|
|
196 | (4) |
|
10.3 Intramuscular Injection of Medication |
|
|
200 | (3) |
|
10.4 Dextroamphetamine Sulphate (Dexedrine®) |
|
|
203 | (1) |
|
10.5 Relative Effectiveness of Common Anti-motion Sickness Drugs |
|
|
204 | (1) |
|
10.6 Other Anti-motion Sickness Drugs |
|
|
205 | (6) |
|
10.7 Theoretical Considerations |
|
|
211 | (3) |
|
|
214 | (1) |
|
|
214 | (5) |
11 The Use of Non-pharmacological Therapy |
|
219 | (28) |
|
11.1 RAF Desensitisation Programme |
|
|
220 | (6) |
|
11.2 USAF Behavioural Airsickness Management (BAM) |
|
|
226 | (1) |
|
11.3 USAF Biofeedback Training |
|
|
227 | (3) |
|
11.4 Canadian Forces Airsickness Rehabilitation Programme |
|
|
230 | (2) |
|
11.5 US Navy Motion Sickness Prevention Programme Based on Transfer of Adaptation |
|
|
232 | (1) |
|
11.6 US Navy Self-paced Airsickness Desensitisation (Spad) |
|
|
233 | (2) |
|
11.7 Autogenic-Feedback Training |
|
|
235 | (2) |
|
11.8 Evaluation of Autogenic Training and Biofeedback |
|
|
237 | (2) |
|
11.9 Review of Military Desensitisation Programmes |
|
|
239 | (1) |
|
11.10 Independent Comment on Desensitisation Programmes |
|
|
240 | (1) |
|
11.11 Other Methods Used to Treat Motion Sickness |
|
|
241 | (2) |
|
|
243 | (1) |
|
|
244 | (3) |
12 Cognitive-Behavioural Desensitisation Training-The Principles of My Original Programme Using a Rotating/Tilting Chair |
|
247 | (28) |
|
12.1 Cognitive-Behavioural Training-Historical Perspective |
|
|
248 | (5) |
|
12.2 Rationale of Cognitive-Behavioural Training |
|
|
253 | (6) |
|
12.3 Practical Application Using the Rotating Tilting Chair |
|
|
259 | (6) |
|
12.4 First Training Session |
|
|
265 | (2) |
|
12.5 Second Training Session |
|
|
267 | (1) |
|
12.6 Type Three Training Session |
|
|
268 | (1) |
|
12.7 Type Four Training Session |
|
|
269 | (1) |
|
12.8 Type Five Training Session |
|
|
269 | (1) |
|
12.9 Type Six Training Session |
|
|
270 | (1) |
|
12.10 Type Seven Training Session |
|
|
270 | (1) |
|
12.11 Type Eight Training Session |
|
|
271 | (1) |
|
12.12 Type Nine and Subsequent Training Sessions |
|
|
271 | (1) |
|
|
272 | (1) |
|
|
272 | (3) |
13 Experimental Evaluation of the Components of Cognitive-Behavioural Training Using Illusory Motion in an Optokinetic Drum |
|
275 | (20) |
|
13.1 Equipment Used for Visually-Induced Apparent (Illusory) Motion |
|
|
276 | (1) |
|
13.2 UNO Optokinetic Drum |
|
|
276 | (2) |
|
|
278 | (4) |
|
13.4 NBDL Desensitisation Chair |
|
|
282 | (2) |
|
13.5 Evaluation of Key Components of Cognitive-Behavioural Desensitisation Training |
|
|
284 | (3) |
|
|
287 | (1) |
|
13.7 Optimal Number of Training Sessions |
|
|
288 | (1) |
|
13.8 Comparison with a Biofeedback Technique |
|
|
289 | (3) |
|
13.9 Theoretical Considerations |
|
|
292 | (1) |
|
|
292 | (1) |
|
|
292 | (3) |
14 Overview of the Uses of Cognitive-Behavioural Training |
|
295 | |
|
|
296 | (1) |
|
14.2 High Altitude Decompression Training |
|
|
297 | (1) |
|
14.3 Cardiac Catheterisation |
|
|
298 | (2) |
|
|
300 | (1) |
|
14.5 Theoretical Considerations |
|
|
301 | (1) |
|
|
301 | (1) |
|
|
302 | |